Mapluxin Trademark Details

Mapluxin was registered on Tuesday, March 3, 1987 and is currently owned by Sandoz Pharmaceuticals Corporation under the registration number 1430849 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 30 years ago on Monday, September 6, 1993, according to the United State Patent & Trademark Office
Word Mark Mapluxin
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sandoz Pharmaceuticals Corporation of East Hanover, NJ

View all trademarks for Sandoz Pharmaceuticals Corporation
Other Trademarks for Sandoz Pharmaceuticals Corporation
Serial Number 73610766
Registration Number 1430849
Status Date Monday, September 6, 1993
Filing Date Monday, September 6, 1993
Registration Date Tuesday, March 3, 1987
Attorney Harold Milstein

Correspondent

HAROLD MILSTEIN
SANDOZ CORPORATION
59 ROUTE 10
E. HANOVER, NEW JERSEY 07936

Case File Statements

Goods & Services Pharmaceutical Preparation, Namely, an Antipsychotic

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Monday, September 6, 1993
First Use Anywhere Wednesday, June 18, 1986
First Use In Commerce Wednesday, June 18, 1986
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.